Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,127.20
(
0.47%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
98.59
(
-2.05%
)
Bitcoin
73,911.58
(
-0.04%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ilpapa

Send PM Follow Ignore
Followers 6
Posts 1313
Boards Moderated 0
Alias Born 11/02/2003

ilpapa

Re: biomaven0 post# 110944

Thursday, 12/16/2010 7:43:58 AM

Thursday, December 16, 2010 7:43:58 AM

Post# of 257253
the FDA did not require "sameness" or complete characterization in approving MNTA's generic:


That can only be interpreted as favorable to TEVA's early approval chances and may explain why MNTA trades like the sword of Damocles was hanging over its head. When the sword falls, the negative effect may be limited.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now